Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2642-2644

  Bogdanov, Mikhail B ^a   Ferrante, Robert J ^b,c   Kuemmerle, Stefan ^b,c   Klivenyi, Peter ^a   Beal, M Flint ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

3 Nitropropionic acid; Free radicals; Huntington's disease; Mitochondria; Oxidative damage; Transgenic mice

Indexed keywords

3 NITROPROPIONIC ACID; 4 HYDROXYBENZOIC ACID; HYDROXYL RADICAL; PROTOCATECHUIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN MITOCHONDRION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE PREDISPOSITION; ENERGY METABOLISM; HUNTINGTON CHOREA; MICRODIALYSIS; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0031797267     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062642.x     Document Type: Article

References (15)

1. Beal M. F., Brouillet E., Jenkins B. G., Ferrante R. J., Kowall N. W., Miller J. M., Storey E., Srivastava R., Rosen B. R., and Hyman B. (1993) Neurochemical and histologic characterization of excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 4181-4191.
2. Beal M. F., Ferrante R. J., Henshaw R., Matthews R. T., Chan P. H., Kowall N. W., Epstein C. J., and Schulz J. B. (1995) 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 65, 919-922.
3. Bogdanov M. B., Ramos L. E., Xu X., and Beal M. F. (1998) Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 71, 1321-1324.
4. Brouillet E., Hantraye P., Ferrante R. J., Dolan R., Leroy-Willig A., Kowall N. W., and Beal M. F. (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. USA 92, 7105-7109.
5. Browne S. E., Bowling A. C., MacGarvey U., Baik M. J., Berger S. C., Muqit M. M. K., Bird E. D., and Beal M. F. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
6. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., and Bates G. P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
7. Gu M., Gash M. T., Mann V. M., Javoy-Agid F., Cooper J. M., and Schapira A. H. V. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 385-389.
8. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
9. 1H NMR spectroscopy in Huntington's. Striatal asymmetries and correlations with CAG repeats. Neurology 50, 1357-1365.
10. 10. Ann. Neurol. 41, 160-165.
11. Ludolph A., Seelig M., Ludolph A., Novitt P., Allen C. N., Spencer P. S., and Sabri M. I. (1992) 3-Nitropropionic acid: exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neural Sci. 18, 492-498.
12. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., and Bates G. P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
13. Matthews R. T., Yang L., Jenkins B. G., Ferrante R. J., Rosen B. R., Kaddurah-Daouk R., and Beal M. F. (1998) Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci. 18, 156-163.
14. Schulz J. B., Henshaw D. R., Siwek D., Jenkins B. G., Ferrante R. J., Cipolloni P. B., Kowall N. W., Rosen B. R., and Beal M. F. (1995a) Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64, 2239-2247.
15. Schulz J. B., Matthews R. T., Jenkins B. G., Ferrante R. J., Siwek D., Henshaw D. R., Cipolloni P. B., Mecocci P., Kowall N. W., Rosen B. R., and Beal M. F. (1995b) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15, 8419-8429.